[HTML][HTML] A novel description of a syndrome consisting of 7q21.3 deletion including DYNC1I1 with preserved DLX5/6 without ectrodactyly: a case report

…, KG Reyes-Perdomo, JA Montes-Gambarelli… - Journal of Medical Case …, 2016 - Springer
Background Chromosomal region 7q21.3 comprises approximately 5.2 mega base pairs
that include genes DLX5/6, SHFM1, and DYNC1I1 associated with split hand/split foot …

A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19

…, KE Pineda Toro, JA Montes-Gambarelli… - medRxiv, 2021 - medrxiv.org
Background Coronavirus disease 2019 (Covid-19) active cases continue to demand the
development of safe and effective treatments. This is the first clinical trial to evaluate the safety …

A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19 (preprint)

…, PNK Leiva, KEP Toro, J Montes-Gambarelli… - 2021 - pesquisa.bvsalud.org
Background Coronavirus disease 2019 (Covid-19) active cases continue to demand the
development of safe and effective treatments. This is the first clinical trial to evaluate the safety …

[PDF][PDF] Universidad Católica De Honduras

CSP y San Pablo - classic.clinicaltrials.gov
1.3 Justification. Coronaviruses are important pathogens in humans and animals, causing
respiratory tract and lung parenchymal infections. In late 2019, a novel coronavirus was …